TipRanks
AbbVie (DE:4AB)
XETRA:4AB
Germany Market
4AB
AbbVie
RESEARCH TOOLSreports

AbbVie (4AB) Stock News & Sentiment

27 Followers
AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors
Premium
Company Announcements
AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors
8h ago
ABBV
AbbVie Wraps Key Early Trial on ABBV-722 Drug Interaction, Supporting Pipeline Confidence
Premium
Company Announcements
AbbVie Wraps Key Early Trial on ABBV-722 Drug Interaction, Supporting Pipeline Confidence
2d ago
ABBV
AbbVie’s Bretisilocin Study Completion Signals Quiet Progress in Early-Stage Pipeline
Premium
Company Announcements
AbbVie’s Bretisilocin Study Completion Signals Quiet Progress in Early-Stage Pipeline
2d ago
ABBV
Analyst Reaffirms Buy Rating on AbbVie, Maintaining $280 Price Target After Strong CERVINO Phase III Data
Premium
Ratings
Analyst Reaffirms Buy Rating on AbbVie, Maintaining $280 Price Target After Strong CERVINO Phase III Data
5d ago
ABBV
Alzheimer’s-Fighting ADARx Pharmaceuticals Set for Near $2B IPO
Premium
Market News
Alzheimer’s-Fighting ADARx Pharmaceuticals Set for Near $2B IPO
11d ago
MS
JPM
AbbVie Targets Dry Eye Market Upside With New ABBV-444 Trial Update
Premium
Company Announcements
AbbVie Targets Dry Eye Market Upside With New ABBV-444 Trial Update
15d ago
ABBV
AbbVie’s ECLIPSE Migraine Trial Completes, Setting Up a New Catalyst for ABBV
Premium
Company Announcements
AbbVie’s ECLIPSE Migraine Trial Completes, Setting Up a New Catalyst for ABBV
21d ago
ABBV
More DE:4AB News >

4AB News on the Web

How to Create a Million-Dollar Stock Portfolio
Zacks
Neutral
Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA) and AbbVie (ABBV)
TipRanks News
Bullish
AbbVie's Zumilokibart Phase 2 Success Highlights Dividend Sustainability Concerns (ABBV)
GuruFocus News
Neutral
AbbVIe's Zumilokibart Meets Phase 2 Goal In Atopic Dermatitis Study
rttnews
Bullish
Citi Keeps Their Hold Rating on AbbVie (ABBV)
TipRanks News
Bullish
Analysts’ Top Healthcare Picks: AbbVie (ABBV), Quantum-Si (QSI)
TipRanks News
Bullish
AI Could Give AbbVie (ABBV) a New Route to Long-Term Pipeline Growth
Insider Monkey
Bullish
Kevin Warsh Just Signaled Higher-for-Longer Rates. Here's What That Means for Big Pharma Dividend Stocks.
The Motley Fool
Bullish

News Score - Last 7 Days

Very Positive
DE:4AB
Sector Average
Media Buzz
This Week40 articles
Weekly Average24 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:4AB’s Media Buzz Sentiment?
40 articles about DE:4AB were published this week. In an average week, 24 articles are published.
    What is DE:4AB’s weekly average amount of articles?
    In an average week, 24 articles about DE:4AB are published.
      What is DE:4AB’s News Sentiment?
      100% of articles about DE:4AB were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        SYRESpyre Therapeutics
        BAYRYBayer
        QTTBQ32 Bio
        CICigna
        ZYMEZymeworks
        Showing the stocks with the most bullish news sentiment over the past week